NMS · Medical - Instruments & Supplies
Kestra Medical Technologies, Ltd. (KMTS) Stock
$25.77
-2.72%
NMS: KMTS
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...
GuruFocus.com · Jul 15, 2026
Kestra Medical Technologies Q4 Earnings Call Highlights
MarketBeat · Jul 14, 2026
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Zacks · Jul 14, 2026
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
GlobeNewswire · Jul 14, 2026
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
GlobeNewswire · Jul 14, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held5.30%
Institutions Held102.47%
Institutions Float Held108.20%
Peer Comparison
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. is led by CEO Brian Webster, employs 300 people, headquartered in US, publicly traded since 2025.
Kestra Medical Technologies, Ltd. (KMTS) stock trades at $25.77 with a market capitalization of $1.51B. The stock is valued at a price-to-earnings (P/E) ratio of -10.27, price-to-book of 7.22, price-to-sales of 15.06. Over the past 52 weeks the stock has ranged between $17.34 and $30.00, and currently trades 14.1% below its 52-week high.
On profitability, Kestra Medical Technologies, Ltd. generates a return on equity (ROE) of -64.18%, return on capital employed of -47.99%, an operating margin of -176.67%, a net profit margin of -140.43%.